Maravai LifeSciences Holdings Inc (MRVI)
8.785
+0.36
(+4.33%)
USD |
NASDAQ |
May 02, 16:00
8.785
0.00 (0.00%)
After-Hours: 20:00
Maravai LifeSciences Holdings Debt to Equity Ratio: 1.258 for Dec. 31, 2023
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
Date | Value |
---|---|
December 31, 2023 | 1.258 |
September 30, 2023 | 1.011 |
June 30, 2023 | 1.01 |
March 31, 2023 | 1.010 |
December 31, 2022 | 0.9674 |
September 30, 2022 | 1.049 |
June 30, 2022 | 1.159 |
March 31, 2022 | 1.385 |
December 31, 2021 | 1.682 |
Date | Value |
---|---|
September 30, 2021 | 1.756 |
June 30, 2021 | 2.746 |
March 31, 2021 | 4.738 |
December 31, 2020 | 6.040 |
September 30, 2020 | -6.690 |
June 30, 2020 | |
March 31, 2020 | |
December 31, 2019 | 2.385 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
-6.690
Minimum
Sep 2020
6.040
Maximum
Dec 2020
1.434
Average
1.258
Median
Dec 2023
Debt to Equity Ratio Benchmarks
Debt to Equity Ratio Related Metrics
Total Assets (Quarterly) | 1.487B |
Total Liabilities (Quarterly) | 697.57M |
Shareholders Equity (Quarterly) | 416.75M |
Current Ratio | 8.002 |
Net Debt Paydown Yield | 0.10% |